Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate
Combination drug From Wikipedia, the free encyclopedia
Combination drug From Wikipedia, the free encyclopedia
Estradiol dibutyrate/hydroxyprogesterone heptanoate/testosterone caproate (EDBu/OHPH/TCa), sold under the brand name Triormon Depositum, is an injectable combination medication of estradiol dibutyrate (EDBu), an estrogen, hydroxyprogesterone heptanoate (OHPH), a progestogen, and testosterone caproate (TCa), an androgen/anabolic steroid, which was used in the treatment of menopausal symptoms in women.[1] It contained 3 mg EDBu, 30 mg OHPH, and 50 mg TCa in oil solution and was administered by intramuscular injection.[1] The medication was developed by 1957.[1] It is no longer available.[2][3]
Combination of | |
---|---|
Estradiol dibutyrate | Estrogen |
Hydroxyprogesterone heptanoate | Progestogen |
Testosterone cyclohexylpropionate | Androgen; Anabolic steroid |
Clinical data | |
Trade names | Triormon Depositum |
Other names | EDBu/OHPH/TCa |
Routes of administration | Intramuscular injection |
Seamless Wikipedia browsing. On steroids.
Every time you click a link to Wikipedia, Wiktionary or Wikiquote in your browser's search results, it will show the modern Wikiwand interface.
Wikiwand extension is a five stars, simple, with minimum permission required to keep your browsing private, safe and transparent.